Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD).
发现帕拉塞斯特兰（OP-1250），一种强效且口服生物利用度高的完全雌激素受体拮抗剂（CERAN）和选择性雌激素受体降解剂（SERD）
期刊:ACS Omega
影响因子:4.3
doi:10.1021/acsomega.4c11023
Ng Raymond A, Barratt Susanna, Parisian Alison, Palanisamy Gopinath S, Phukan Samiron, Sun Richard, Robello Brandon, Peña Guadalupe, Sapugay Judevin, Yeghikyan David, Wang Chenbo, Satish Kher Samir, Thangathirupathy Srinivasan, Millikin Robert, Yu Guijun, Watanabe Teruki, Zhou Fei, Rich Brian, Duncan Alexis, Andersen Samuel E, Chawla Reena, Zak David R, Heerding Dirk A, Hearn Brian R, Greene Geoffrey, Harmon Cyrus L, Hodges-Gallagher Leslie, Kushner Peter J, Fanning Sean W, Myles David C
